Two Seas Capital LP - Mar 31, 2025 SCHEDULE 13G/A Report for Adaptimmune Therapeutics PLC Ordinary Shares, par value GBP 0.001 per share (ADAP)

Filing Manager: Two Seas Capital LP
Reporting Manager: Two Seas Capital LP
Security: Adaptimmune Therapeutics PLC Ordinary Shares, par value GBP 0.001 per share
Symbol: ADAP
Shares outstanding: 1.54B shares
Disclosed Ownership: 123M shares
Ownership: 8%
Form type: SCHEDULE 13G/A
Date filed: 5/15/2025, 09:00 AM
Date of event: Mar 31, 2025
Previous filing: Feb 14, 2025
Next filing: Aug 13, 2025
SEC: View on sec.gov

Reporting Managers (3)

Name	Ownership	Shares Owned	sole voting power	Signature	Title
Two Seas Capital LP	8%	123M	123M	/s/ Sina Toussi	Sina Toussi / Managing Member of Two Seas Capital GP LLC, its General Partner
Two Seas Capital GP LLC	8%	123M	123M	/s/ Sina Toussi	Sina Toussi / Managing Member
Sina Toussi	8%	123M	123M	/s/ Sina Toussi	Sina Toussi / Self